Literature DB >> 10199445

Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment.

R S Chamberlain1, K Huber, J C White, R Travaglino-Parda.   

Abstract

Apocrine gland carcinoma is a rare form of sweat gland neoplasm with a distinctive cytologic appearance. Although the region of the axilla remains the most common site for these tumors, apocrine gland carcinoma of the anogenital region, eyelid, ear, chest, wrist, lip, foot, toe, and finger have been reported. Classically, these slow-growing lesions present as painless, colorless or reddish, firm or cystic nodules. More than half of the reported patients with apocrine carcinoma had lymph node metastases at the time of diagnosis. Wide local excision is standard therapy for these lesions. A therapeutic lymph node dissection is indicated for confirmed lymph node metastases and may have a role in the setting of a large or highly aggressive tumor with narrow surgical margins. Although apocrine gland carcinoma responds poorly to chemotherapy, adjuvant radiotherapy may be used in advanced local or regional disease. The authors describe a 69-year-old man with a large recurrent apocrine gland carcinoma of the axilla treated with en bloc excision with axillary dissection and offer a pertinent review of the English literature and recommendations for treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10199445     DOI: 10.1097/00000421-199904000-00005

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  27 in total

1.  Axillary apocrine adenocarcinoma in a young male suspected initially on fine-needle aspiration cytology.

Authors:  Ranjan Agrawal; Cheena Garg; Arjun Agarwal; Parbodh Kumar
Journal:  J Cytol       Date:  2015 Jul-Sep       Impact factor: 1.000

2.  Primary Cutaneous Apocrine Carcinoma.

Authors:  Seung-Hee Loh; Yu-Jin Oh; Bark-Lynn Lew; Woo-Young Sim
Journal:  Ann Dermatol       Date:  2016-09-30       Impact factor: 1.444

Review 3.  Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands.

Authors:  Nidal A Obaidat; Khaled O Alsaad; Danny Ghazarian
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

Review 4.  Cutaneous apocrine carcinoma in groin with bilateral lymph node metastasis: a case report and review of the literature.

Authors:  Jingjing Guo; Gang Wu; Jinhua Xu; Zhenyu Ma; Zhongwen Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 5.  Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature.

Authors:  T Miyamoto; Y Hagari; S Inoue; T Watanabe; T Yoshino
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

6.  Brain metastases from apocrine carcinoma of the scalp: case report.

Authors:  Shinji Shimato; Toshihiko Wakabayashi; Masaaki Mizuno; Norimoto Nakahara; Hisashi Hatano; Atsushi Natsume; Dai Ishii; Yasuhisa Hasegawa; Ikuo Hyodo; Tetsuro Nagasaka; Jun Yoshida
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

7.  [Atypical course of an apocrine sweat gland carcinoma of the axilla : A very rare malignant tumor and its interdisciplinary treatment].

Authors:  U Wauer; D Lorenz; R Sellei; E Zoga; S Braun
Journal:  Hautarzt       Date:  2017-10       Impact factor: 0.751

8.  Metastatic apocrine sweat gland adenocarcinoma in a terrier dog.

Authors:  Akhtardanesh Baharak; Kheirandish Reza; Dabiri Shahriar; Azari Omid; Vosoogh Daruoosh; Askari Nasrin
Journal:  Asian Pac J Trop Biomed       Date:  2012-08

9.  Management of Metastatic Apocrine Hidradenocarcinoma with Chemotherapy and Radiation.

Authors:  Daniel H Miller; Jennifer L Peterson; Steven J Buskirk; Laura A Vallow; Randy Ta; Richard Joseph; Murli Krishna; Stephen J Ko; Katherine S Tzou
Journal:  Rare Tumors       Date:  2015-10-05

10.  Poorly Differentiated Scrotal Carcinoma With Apocrine Immunophenotype.

Authors:  Sonia Kamanda; Jonathan I Epstein; Adeboye O Osunkoya; Ashley Cimino-Mathews; Pedram Argani; Martin Sangüeza; Jose Antonio Plaza; Andres Matoso
Journal:  Am J Dermatopathol       Date:  2022-04-01       Impact factor: 1.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.